Results 291 to 300 of about 7,950,605 (408)
Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu+11 more
wiley +1 more source
STUDIES OF RIBOSE METABOLISM. III. THE PATHWAY OF RIBOSE CARBON CONVERSION TO GLUCOSE IN MAN1 [PDF]
Howard H. Hiatt
openalex +1 more source
The genomic landscape of esophageal squamous cell carcinoma cell lines. [PDF]
Zhang C+5 more
europepmc +1 more source
This study used longitudinal transcriptomics and gene‐pattern classification to uncover patient‐specific mechanisms of chemotherapy resistance in breast cancer. Findings reveal preexisting drug‐tolerant states in primary tumors and diverse gene rewiring patterns across patients, converging on a few dysregulated functional modules. Despite receiving the
Maya Dadiani+14 more
wiley +1 more source
The oxidative pathway of carbohydrate metabolism in Escherichia coli. 3. Glucose 6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase in cells grown under different conditions [PDF]
Dwight B. McNair Scott
openalex +1 more source
Integrating multi-omics data to identify the role of Aggrephagy-related genes in tumor microenvironment and key tumorigenesis factors of GB from the perspective of single-cell sequencing. [PDF]
Chen Z+10 more
europepmc +1 more source
B‐cell chronic lymphocytic leukemia (B‐CLL) and monoclonal B‐cell lymphocytosis (MBL) show altered proteomes and phosphoproteomes, analyzed using mass spectrometry, protein microarrays, and western blotting. Identifying 2970 proteins and 316 phosphoproteins, including 55 novel phosphopeptides, we reveal BCR and NF‐kβ/STAT3 signaling in disease ...
Paula Díez+17 more
wiley +1 more source
THE USE OF METABOLICALLY BLOCKED ORGANISMS FOR THE ANALYSIS OF BIOSYNTHETIC PATHWAYS [PDF]
Edward A. Adelberg
openalex +1 more source
Ubiquitination of transcription factors in cancer: unveiling therapeutic potential
In cancer, dysregulated ubiquitination of transcription factors contributes to the uncontrolled growth and survival characteristics of tumors. Tumor suppressors are degraded by aberrant ubiquitination, or oncogenic transcription factors gain stability through ubiquitination, thereby promoting tumorigenesis.
Dongha Kim, Hye Jin Nam, Sung Hee Baek
wiley +1 more source